Chairman Emeritus Peter C. Farrell

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Poway, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Peter C. Farrell, Chairman emeritus
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Chairman Emeritus Peter C. Farrell

Form 4 holding Director

Evolus, Inc.

Security class
Common Stock
Shares / value
43,174
Estimated value
$420,023
Report date
27 Jan 2023
Price
$9.73
Ownership
Direct
Form 4 holding Director

RESMED INC

Security class
ResMed Common Stock Options
Shares / value
1,331
Estimated value
$333,442
Report date
24 Nov 2025
Price
$250.52
Ownership
Direct
Underlying class
ResMed Common Stock
Underlying amount
Form 4 holding Director

Evolus, Inc.

Security class
Common Stock
Shares / value
10,000
Estimated value
$97,286
Report date
27 Jan 2023
Price
$9.73
Ownership
By trust
Form 4 holding Director

Arcturus Therapeutics Holdings Inc.

Security class
Deferred Stock Units
Shares / value
0
Estimated value
$0
Report date
14 Jun 2024
Price
$32.03
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Evolus, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
11,789
Estimated value
Report date
27 Jan 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Chairman Emeritus Peter C. Farrell

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .